Our visionary team brings a wide range of different expertise to the table, all to meet a single goal — helping our clients navigate the complexities of today’s life sciences industry through vision and innovative solutions.
Dave has been helping life sciences companies bring cutting edge medicines and medical devices to the market for more than two decades. Joining Trinity as Employee #3 as an Associate after college, Dave has led Trinity’s growth of 20% year over year, developing and implementing best practices for new product and launch planning, due diligence for licensing and acquisitions, as well as industry-leading forecasting methods — experience that led Consulting Magazine to name him a 2017 Global Leader in Consulting.
When Dave isn’t driving commercialization forward for life science companies, he is often driving his 3 boys to school and various sporting events. He’s also active in the Concussion Legacy Foundation, which advances the study, treatment and prevention of the effects of brain trauma in athletes and other at-risk groups, a cause he is passionate about. Dave earned an AB from Harvard University.
Leslie oversees the delivery of integrated consulting, insights and analytic services to our customers. Since joining Trinity, she has been a critical advisor to hundreds of customers across thousands of projects, spanning an array of therapeutic areas and business models. Her support for billions of dollars in strategic transactions and the launches of dozens of products gives Leslie a unique vantage point on the industry, and her evidence-forward approach to strategic questions empowers customers to make smart, informed and timely decisions.
Leslie graduated summa cum laude and Phi Beta Kappa from Dartmouth College with a BS in Biology. While at Dartmouth, she was also an All-American and captain of the National Championship varsity sailing team. She spends her down time chasing around her two girls and spending as much time at the beach, ski slopes and horse barn as possible.
Rebecca leads Trinity’s world-class finance and operations teams. She has a proven track record for leading growth strategies as well as complex operational initiatives and capital allocation strategies. Rebecca has dedicated much of her career to helping organizations successfully grow technology-enabled businesses through organic investments as well as M&A. She enjoys building and leading high-performing, collaborative finance and operations teams that provide critical strategic partnerships to leaders across the organization. She previously held several senior positions at Cengage, a higher education technology company, including Chief Integration Officer, Interim CFO, and Head of FP&A and Investor Relations. She also held finance and development roles at Thomson Reuters and TheStreet.com.
Rebecca holds a bachelor’s degree in economics from Lehigh University and an MBA, specializing in Finance and Economics, from Columbia Business School.
When Rebecca isn’t working, she enjoys traveling and spending time outdoors with her family. On weekends, she can most often be found on the sidelines of a soccer game for one of her 3 kids.
Since founding Trinity in 1996, John has cultivated the heavily quantitative, cross-functional approach to consulting that has remained at the core of the company throughout its expansion of service offerings and its international growth of team members and offices.
Trinity marks the fourth company John has founded or co-founded, after successful endeavors in social media, medical devices, and pharma- and biotech-focused software development.
He graduated magna cum laude from Harvard College before earning his M.A. from Northeastern and his M.C.R.P. from the John F. Kennedy School of Government at Harvard, and he devotes his free time to his family.
Gary is a seasoned pharmaceutical industry professional with more than 20 years’ experience in marketing and sales. Previously, he led the day-to-day management and commercialization of all TGaS Advisor solutions and headed the Marketing Advisory Practice. Earlier in his career, Gary consulted with Abbott Laboratories as they built out a Respiratory Marketing group and spent four years at Kos Pharmaceuticals where he served in a number of marketing positions, including Group Director, Respiratory and Hypertension brands. He started his pharmaceutical career at Schering-Plough, where he held a variety of sales, marketing and management positions.
Gary holds a BA in Advertising from the School of Communications at Temple University. In his free time, Gary enjoys traveling with his family, and is an avid golfer.
Eric is responsible for the oversight of Trinity’s Value and Access division. This includes all functions within Global Market Access, U.S. Market Access, and Health Economics and Outcomes Research (HEOR). For over 20 years, he has served as a valued advisor to hundreds of market access clients across the rare disease, specialty therapies, and general medicines segments. Prior to joining Trinity, Eric held executive leadership roles with Artisan Healthcare Consulting and Decision Resources Group. He also spent many years developing commercial and market access experience in various roles with G.D. Searle & Co. and Biogen. Eric holds a BSBA from Fordham University and an MBA from the F.W. Olin Graduate School of Business at Babson College.
Eric is an avid outdoorsman, spending his free time skiing, mountain biking, and hiking the backcountry of Northern Vermont.
Tim is a veteran of the healthcare and technology space – contributing to many new solutions for customers along the way. He joined Trinity with the acquisition of TGaS Advisors, where he led product innovation and strategy for 4 years. Previously, he was Co-President of Millennium Research Group (now part of DRG) and founded an advisory firm focused on the energy and healthcare industries. He also gets excited by renovating century homes.
Tim is a graduate of the University of Waterloo where he majored in psychology and played volleyball. Outside of work, Tim is involved as a board member and volunteer with several local organizations focused on immigration and community building.
Sr. Vice President Client Development
Jeff has been working in the life sciences industry for over 20 years in the supply chain, patient journey, and marketing access helping pharmaceutical manufacturers get product to patients while managing through adherence challenges. Over the last decade, he has helped build a start-up service organization to an industry leader while creating a professional Client Development team. Jeff has recently joined Trinity to expand our Client Development function and assist in our organization’s overall growth.
Jeff received his Bachelor of Science in Marketing from the University of Connecticut. He specializes in strategic business alliances and complex solution to large and medium enterprises.
In his free time, Jeff enjoys giving back to youth sports in his local area.
Herman has been working in the life sciences industry for over 20 years in various positions including designing and running randomized trial research, optimizing of clinical administration of health services, and working as a strategic consultant to the life sciences industry. He joined Trinity over a decade ago and has worked closely with clients to support strategic decision making across the product lifecycle. As a leader at Trinity, he has worked to build out of Trinity’s European office and helps to run and build our centers of excellence in Market Access, Launch, and Health Economics and Outcomes Research (HEOR).
At home, when he isn’t reading, he enjoys jumping on the trampoline with his two kids and wife and cooking various types of meals. He is a proud supporter of Peace First, which empowers young people to change the world around them, where in college he served as one of the organization’s leaders and has been an active contributor and consultant since (https://www.peacefirst.org/). Herman earned an MBA from the Tuck School of Business at Dartmouth and an AB from Harvard University, where he played rugby and sang in the gospel choir (Kuumba).
Neal is a member of the Executive Committee helping to set and deliver on Trinity’s core strategic imperatives. As Head of Insights & Analytics, Neal and his team provide Trinity’s clients with strategically sound and tactically actionable results to critical brand questions through a breadth of marketing research, real world evidence and commercial analytic methodologies. Previously, Neal led Trinity’s Primary Market Research group for 10 years building a nascent business into a core practice area. Prior to joining Trinity, Neal worked for a boutique market research firm where he helped build strong client relations and internal operations as a member of its executive team. He began his career at Bristol-Myers Squibb in brand management and marketing research for in-line and pre-launch products.
Neal earned a B.S. in Neurobiology and Behavior at Cornell University. Outside of the office, Neal is devoted to living a fit active life with his family, enjoying triathlon, skiing, paddling and photography.
Steve draws on 15 years of experience in the global life science industry to provide leaders and companies with innovative commercial strategy support. As a partner, his leadership has helped grow Trinity into one of the top life science consultancies with an enhanced focus on people development and culture. Steve focuses on commercialization strategy including new product planning, licensing and acquisition support, launch excellence and in-line operational support. An industry leader in key commercialization areas such as forecasting, Steve has presented on best practices and innovation in the space. Steve holds an undergraduate degree from Princeton University and an MBA from the Carroll School of Management at Boston College. When not at Trinity, Steve can be found spending time with his family including 3 children.
Glen is a Partner, Strategic Advisory at Trinity Life Sciences. Glen has expertise in marketing strategy and launches planning across several therapeutic areas which include HIV, Hepatitis B&C, Schizophrenia, Depression, Bipolar Disorder, Insomnia, PAD, MI, Stroke, Anti Infectives, and Substance Abuse.
Glen led global and US research efforts specific to strategy and execution in the highly successful launches of BMS brands Reyataz (HIV) and Baraclude (Hepatitis B). He also spent time leading the research efforts in support of the world’s second-largest drug(Plavix).
Prior to starting, Glen was Senior Director of Market Research at Schering Plough, where he led the Neuroscience, Virology (HIV/Hepatitis C), Substance Abuse, and Anti Infectives Market Research Teams. Prior to this, Glen worked at Bristol-Myers Squibb for seven years. Glen also has prior marketing consulting experience at Time Inc, where he worked to improve customer targeting, acquisition, and retention for the magazine (Time, People, Fortune, Money, etc) and book business.
Glen holds an MS in Economics and Applied Statistics from the University of North Carolina at Charlotte.
Bala has expertise in marketing strategy and launch planning across several therapeutic areas which include Asthma, COPD, Diabetes, HIV, Hypertension, Hepatitis B&C, Pain, Alzheimer’s Disease, Schizophrenia, Depression, Bipolar Disorder & Insomnia.
His experience also includes sales force & managed care strategy and in-depth knowledge of the US health care payer environment. Prior to joining, Bala was Director of Market Research at Organon, a part of Schering-Plough where he led the Neuroscience Market Research Team working on developing the global launch strategy and execution plan for a new drug for Schizophrenia and Bipolar Disorder. Prior to this Bala, worked at Bristol-Myers Squibb in their Global Hepatitis & HIV Franchise. Bala has prior consulting experience working on several projects related to launch planning across several therapeutic categories.
Bala holds an MS in Transportation Planning from Pennsylvania State University and a BS in Civil Engineering from the Indian Institute of Technology, Bombay.
Ryan has led global market research efforts for several launch products in Oncology, Virology, Diabetes and has in-depth experience in special populations research (Orphan Drugs). Ryan has advanced modeling expertise and has successfully managed & executed major global conjoint studies for therapeutic area valuation/M&A while a partner at Trinity.
Prior to joining, Ryan was Director of Market Research at Vertex Pharmaceuticals and Associate Director of Market Research at Bristol-Myers Squibb. Ryan also has medical device experience and payer experience from his role at Johnson & Johnson Health Care Services. Furthermore, Ryan has consulting experience from his days work at Keane, Inc where he was stationed at DuPont as an analyst within the Agricultural Business.
Ryan holds a Master’s of Marketing Research from the University of Georgia and a BA from Coastal Carolina University.
John has been providing commercial data strategy and innovative data management and business intelligence solutions to life sciences companies for nearly two decades. A founding member of a former Trinity subsidiary, Shyft Analytics, John has been involved in a breadth of projects over the years, leveraging complex data sets, analytics and technology to deliver the best solution for our clients.
John attended Boston University for Computer Science. When John isn’t focused on the continued growth of Trinity’s Commercial Data Solutions, he can be found spending time with his family.
Managing Partner, EU Office
Alexander leads Trinity’s operations in Europe. He brings over two decades of experience as a Management Consultant in the life sciences industry. Alexander advices life sciences executives and investors on complex issues that require strong content expertise and analytical rigor paired with creativity and a deep understanding of the industry success logic. He supports his clients mainly in franchise strategy, launch planning, go-to-market strategy, product positioning, lifecycle management, corporate growth strategy and commercial excellence.
Alexander very much enjoys working in teams and is passionate about developing people.
Alexander lives in Munich and works globally with his clients, after having spent extended periods of time in New York, Johannesburg and Jakarta. He has already advised more than 70 clients in far over 300 strategic assignments covering all continents and more than 40 countries.
Outside of work, Alexander enjoys traveling and spending time with his wife, daughter and son. He is a true foodie and passionate cook.
Alexander has studied business administration in Germany, UK and USA.
Alex has supported biopharmaceutical companies with commercialization challenges for over ten years. A trusted adviser of his clients known for his ability to bring clear, actionable solutions to complex questions, Alex has years of experience bringing the right mix of evidence to advise clients with issues ranging from New Product Planning, pre-launch Commercialization, and Business Development strategy. Now the head of Trinity’s New York City Office and one of the leaders of the firm’s oncology practice, Alex started at Trinity out of college as an associate.
Alex holds a BA from Princeton University and an MBA from Columbia University. When not in the office, Alex can be found exploring the nooks and crannies of his adopted home of Brooklyn with his wife, daughter, and dog.
Aparna leads the design and execution of primary market research projects in support of Trinity’s consulting engagements. She specializes in shaping therapeutic area commercial strategy through insights and analytics across multiple disease areas. Aparna’s focus is on helping clients identify the “right” business questions, developing a hypothesis-based approach to address the question and leveraging her analytical capabilities to identify the most efficient approaches to testing the hypotheses.
With over a dozen years of domestic and international experience in pharmaceutical market research, Aparna holds a PhD with a concentration in Pharmaceutical Market Research from the University of Georgia and is a trained pharmacist. Winning praise for her health care policy research, she has been an invited speaker to the Federal Drug Administration (FDA), and her quantitative research has been widely published in public policy, health communication, pharmacy education and pharmacoeconomic journals.
Outside the office, Aparna enjoys staying active with her husband and sons, particularly kickboxing and crossfit training.
Lauren has been working for over 15 years in life sciences consulting, helping biotech and pharma companies bring solutions to strategic issues across the product lifecycle. Joining Trinity in 2005, Lauren is most valued for the strategic insights she brings and the long term partnerships she has developed with countless clients and companies. While her expertise spans across many project types, Lauren is most known for her work in New Products Planning and due diligence support. Lauren spearheaded the creation of Trinity’s menu of BD support offerings, including Trinity’s proprietary QuickQuant.
Lauren earned a BA from Princeton University, where she played field hockey. She also earned an MBA from the Carroll School of Management at Boston College. Outside of Trinity, Lauren can be found chasing after her three young children and getting her competitive spirit out in an adult field hockey league.
Nandini has over 20 years of experience identifying and actualizing success drivers in the marketplace for life science customers. She specializes in assessing market opportunities, developing arguments to “make the use case” for payers, healthcare professionals, patients and consumer groups, and building compelling scientific evidence. Leveraging best-in-class approaches in qualitative/quantitative research, claims, real-world evidence, health economics modeling, and strategy, Nandini’s focus is helping customers get appropriate share and access, with pricing commensurate to product value. Prior to Trinity, Nandini led the Commercialization Strategy Group for United BioSource Corporation /Evidera. The lead feature in Boston Herald’s “Women Leaders under 40” in 2010, Nandini is published extensively in peer-reviewed publications and has discussed drug pricing at the Yale Healthcare Conference.
Nandini has a BA from the University of Connecticut and MA in Economics from Boston University. When not at Trinity, Nandini can be found attending myriad sporting and school events with her kids, or at home, cooking, gardening and socializing with neighbors.
Eric has been working with the life sciences industry to address a range of strategic needs for nearly two decades. With expertise in new product planning, business development, and launch planning/strategy, he helps companies to identify, evaluate, and execute on new global growth opportunities at the corporate, franchise, and product levels. Prior to joining Trinity, Eric worked with Boston Biomedical Consultants, a leading provider of consulting services to the In Vitro Diagnostics Industry.
Eric received a BA in neuroscience with honors from Middlebury College and his MBA from the Tuck School of Business. Outside of work, Eric can be found spending time with his family, including coaching his three sons in a variety of sports.
Yogi has over 15 years of experience in the life sciences industry and advises clients on a wide range of strategic decisions. He has overseen hundreds of engagements supporting established as well as emerging life sciences companies over his career. Yogi brings expertise in new product planning, corporate and franchise strategy, and business development support. His engagements span the healthcare spectrum, including projects on drugs, devices, diagnostics and digital solutions. Yogi also advises private equity firms, venture capital funds, and other financial services firms on strategies and potential investments in the healthcare sector. At Trinity, he has supported the expansion of the advisory business, which has grown ten-fold since he joined the firm in 2005. Internally at Trinity, Yogi has spearheaded several growth efforts, including the firm’s global expansion (to Europe and India), innovation and product development, and strategic M&A.
Outside of work, Yogi enjoys traveling to spend time with friends and extended family who are spread across several continents. He is a fan of Pearl Jam, cricket, and Chef Jacques Pepin, and has a newfound love of cooking. He currently lives with his wife and son in Washington, DC.
Yogesh earned his Masters of Engineering Management from Dartmouth College and a BE from the University of Mumbai.
Krista supports biopharma and biotech companies in their new product planning, launch strategy & planning, and commercialization readiness. She leads Trinity’s launch excellence group, supporting the development and management of dozens of launches annually. Krista partners with companies focused on their 1st commercial launch to their 50th, bringing deep expertise in rare diseases. Clients leverage Krista’s experience and insights in navigating early-mid clinical stage product development opportunities and the commercial needs required to recognize their full potential, specializing in cross-functional activities that warrant communication & alignment.
Krista joined Trinity in 2006 and co-leads the SF office. Krista studied psychology and pre-med while obtaining her B.A. from Dartmouth College. She enjoys spending time outside with her family in Idaho.
Karthik Badri brings to the team his experience across a wide range of commercial solutions for the biopharmaceutical industry, including new product planning, portfolio strategy, launch planning, and business development.
Karthik has deep experience across the entire asset commercialization spectrum (from early asset identification to launch planning & execution). Karthik has worked with early asset teams to identify the competitive landscape, commercial viability, as well as potential business development opportunities at both an asset and a portfolio level. He has helped numerous new product planning teams (at both large pharma and smaller biotechs) identify optimal commercial models to ensure an efficient asset pipeline process. Karthik also specializes in launch excellence and has supported the launch of numerous products both in the US and globally. His typical projects include launch and go-to-market strategy, launch execution, launch readiness and annual brand planning support. He has worked across multiple therapeutic areas but focuses on Oncology, CNS, and Rare Diseases.
Prior to joining, Karthik was a Partner at Decision Resources Group. His other work experiences include Herspiegel Consulting, Quintiles, and Deloitte Consulting. Karthik received his electrical engineering degree from Delhi College of Engineering, Delhi, and his MBA from Kenan-Flagler Business School at UNC-Chapel Hill.
Rob has extensive experience working with pharmaceutical & biotechnology companies on various strategic issues, including brand / portfolio strategy, launch preparation, patient journey / buying process, customer segmentation, demand estimation, market opportunity assessment, and pipeline / business development strategy. Rob is well versed in utilizing a broad set of research techniques (qualitative and quantitative) and secondary data to deliver evidence-based recommendations for driving commercial decision making. Rob has worked on engagements spanning several therapeutic areas, including oncology, HCV, HIV, antibiotics, diagnostics, and obesity. Prior to joining, Rob worked as an Engagement Manager at ZS Associates, a Senior Associate at a life sciences venture capital firm, and an Analyst at a life sciences investment banking firm. Rob holds a BBA in Finance from the University of Notre Dame and an MBA from UC Berkeley.
Colin is a seasoned marketing researcher and strategist with 10+ years of agency-side experience. Much of his recent work has focused on strategic pricing and contracting, market access and reimbursement, forecasting, and positioning in support of pre-launch products in the areas of CNS, oncology, oncology supportive care, diagnostics, and hematology. Colin held numerous leadership positions (Vice President, Research & Client Service, and Vice President, Head of Research) at RG+A prior to joining.
Paul has extensive experience working with pharma and biotech companies supporting brand commercialization strategy & execution. Much of his recent work has focused on positioning and messaging platform development, market landscaping, buying process and opportunity assessments to inform pre-launch go-to-market strategies. Prior to joining, Paul served as Director of Business Development at Cello Health Insight. Paul has his Ph.D. in Molecular Biology and Biochemistry from the University of Brunel, London and University of Birmingham.
Julie has a wide range of both qualitative and quantitative marketing research experience supporting strategic decision making along the commercialization spectrum, including opportunity assessment, patient journey, customer segmentation, demand estimation, brand positioning and evaluation/refinement of marketing materials. Julie’s experience also spans a broad set of therapeutic areas, including CNS disorders (Depression, ADHD, Parkinson’s, Migraine, Sleep Disorders, MS), CV Disease, Diabetes & associated complications, HCV, HIV, Pulmonary Embolism, Oncology, RA and Women’s Health. Prior to joining, Julie was a Consultant at ZS Associates and also holds an MBA from Kellogg School of Management at Northwestern.
Omer has experience advising global pharmaceutical/biotech clients across a range of commercialization disciplines, spanning market research (qualitative and quantitative), brand strategy, analytics, and sales force strategy & effectiveness. During his tenure, Omer has held multiple marketing leadership roles, including interim brand lead with P&L responsibility for a portfolio of immunology and GI products, leading the launch and management of hub services for a Women’s Healthcare device, and helping to reshape the customer experience for an established player in the eye care space to confront a rapidly changing landscape. He has managed over 250 primary market research studies across various methodologies and therapeutic areas. Prior to joining, Omer was a Consultant at ZS Associates and also holds a BBA with High Distinction and minor in Statistics from the Stephen M. Ross School of Business at the University of Michigan.
Kim Morneau has 15 years of experience in the healthcare industry with deep expertise in pre-launch commercialization strategy and forecasting. Kim has held senior-level market research and forecasting roles on both the client and agency sides of the business. Prior to joining, Kim was Senior Vice President of Commercial Strategy and Forecasting at Ipsos where she was responsible for creating a suite of financial projection tools geared towards pre-launch compounds and medical devices in all stages of clinical development. She also spent six years at Bristol-Myers Squibb as Director of Neuroscience. Kim has an MBA from Stern School of Business, New York University. She was awarded the Best of Business Intelligence Award from BHBIA in 2007.
Rathi is an Partner, Strategic Advisory at Trinity Life Sciences.
She has deep expertise in informing strategic decisions across the brand commercialization timeline, leading projects focused on opportunity assessment, patient journey and demand estimation to the development of positioning and the creation/evaluation of marketing materials. She is well-versed in global market research employing both qualitative and quantitative techniques. Rathi has a broad range of experience across a variety of therapeutic areas including but not limited to Oncology, Neuroscience (Alzheimer’s Disease, Depression, Parkinson’s, Schizophrenia), Metabolic and CV Disease, and Women’s Health.
Prior to joining, Rathi was a manager at ZS Associates where she focused on marketing strategy and sales force effectiveness for clients in the healthcare vertical. She holds a B.S. in Biotechnology from Rutgers University, and Ph.D. in Genetics and Development from Columbia University.
Executive Vice President - Head of SPARC
Prior to joining TRINITY, Joe was Senior Vice President, Professional Marketing & Managed Markets at Euro RSCG Life in New York/Princeton, where he was responsible for commercial strategy and business development. He has also held senior leadership positions for Novartis, Bayer, BMS, and Covance.
At Covance, Joe was Vice President of Corporate Marketing, where he was responsible for the strategic commercial integration of the drug development process. He played key strategic roles at BMS as Sr Director of Global Marketing for the HIV franchise (three product launches) and, as Vice President of Marketing, BMS Canada (five product launches), where he was responsible for oncology, cardiovascular, diabetes, HIV, neuroscience and anti-infective portfolios. At Bayer Diagnostics, Joe was responsible for creating and leading their first managed care group representing the pharma and diagnostics divisions’ portfolios.
Joe has an Engineering degree from Boston University, an MBA from Fairleigh Dickinson University, and is a graduate of Columbia University’s Strategic Marketing Executive program.
Lisa has partnered with life sciences clients to glean actionable insights from market research for over a decade. As the head of the qualitative research center of excellence, she has helmed numerous qualitative engagements with a variety of stakeholders and across multiple TAs including novel Oncology, infectious diseases, women’s health and CNS products. Patient centric work is also a passion for Lisa and during her tenure at Trinity she has worked to develop innovative offerings to better understand the emotional underpinnings of the patient experience.
Lisa holds a Ph.D. in clinical psychology from University of Toledo and is a licensed clinical psychologist. In her spare time, Lisa enjoys traveling, reading and attending lectures, and spending time with family. She is also active in community service organizations and a member of the board for her local rowing club.
Clive designs and applies sound market research methodologies and analytics to generate meaningful insights of commercial importance to the industry. His research expertise spans all facets of commercial development and across many disease areas. Clive leads the research innovation team at Trinity with a continued focus on bringing academic rigor to our research projects and ensuring research insights are anchored in the realities of the market. In this role, he establishes best practices for research analytics at Trinity with the goal of helping inform our clients’ strategic objectives with compelling story telling.
Clive trained as a pharmacist before earning a PhD in Pharmaceutical Marketing and Outcomes Research. His academic research has been published in peer-reviewed journals and has been recognized at numerous conferences.
Clive is an avid traveler and “foodie” and is always planning where his next adventure or meal is going to be at.
Matt joins Trinity with over 20 years of life sciences consulting experience. During his career, Matt has worked with both pharmaceutical and medical device clients across business/commercial strategy (pricing, market access, product portfolio rationalization, acquisitions, Intellectual Property, and market insights), HEOR (value proposition development, evidence generation planning, and literature reviews, budget impact and comparative effectiveness models, etc.) and medical communications (value dossiers, abstracts/posters for conferences and manuscripts).
Matt focuses on driving strategic insights for clients and delivering innovative HEOR solutions within the broader strategic context of product development, market access, and market shaping/medical communications. Most recently, Matt has been instrumental in the novel application of Real World Evidence to inform product development, quantifying unmet clinical needs and raising overall market awareness. This work resulted in numerous abstracts, posters, peer-review manuscripts and conference presentations.
Matt was recently a featured presenter at the Society of Critical Care Medicine’s 2020 Critical Care Congress and HIMSSS.
Matt earned his a dual degree from Bowdoin College in Government and Environmental Science and an MBA from the Tuck School of Business at Dartmouth College.
Outside of Trinity Matt can be found on the sidelines of various sporting events with his two kids. An avid fly fisherman for over 25 years, when opportunity allows Matt can be found on various rivers in New England or in the Western US.
Jeff supports pharmaceutical, device, and diagnostic companies in demonstrating and communicating the value of their products. His work is informed by broader experiences in market access and business and clinical strategy, allowing him to craft health economics and outcomes research solutions that dovetail with overall strategic plans for products across their life cycle stages. In addition to overall strategic and/or evidence generation plans, Jeff drives the tactical execution of these plans, bringing a deep understanding of multiple disease states and markets, including psychiatric disorders, rare neurological diseases, osteoarthritis, orthopedic surgery, movement disorders, and infectious diseases.
Jeff received an A.B. in Molecular Biology from Princeton University and a Ph.D. in Virology from Harvard University. Outside of work, Jeff can be found running around New York or in the occasional marathon.
Andy has over 13 years of strategy consulting experience and 10 years of scientific training. He advises biopharma clients on strategic decisions at the product, portfolio and corporate levels. He has extensive experience in commercial opportunity assessments, forecasts/valuations, brand strategy/launch, growth strategies and portfolio management. Andy’s expertise spans multiple disease areas and global markets (both Developed and Emerging).
Andy has a BS in Biochemistry and PhD in Medicine from McGill University. He has extensive post-graduate training at Memorial Sloan Kettering Cancer Center and New York University Medical Center. Outside of the office, Andy enjoys spending time with his family and traveling the globe to sample new sights, sounds and tastes.
Kevin’s 20-year career has focused on developing marketing and commercial strategies for new or in-line brands for medical device, diagnostics, and pharmaceutical manufacturers. Prior to joining, Kevin was with IQVIA, ZS Associates, Deloitte, and Rosetta Consulting, working on sales and marketing engagements across the US, Europe, and Asia. Kevin has deep experience in early commercialization strategy, launch planning, patient/customer journey, go-to-market/commercialization strategy and execution, product/portfolio positioning, and value proposition development in a variety of different therapeutic areas for life sciences clients
Kevin has worked across all sectors of the healthcare space, including with hospitals/providers, pharmaceuticals, MedTech and diagnostics manufacturers, and the FDA. Kevin has expertise in vitro diagnostics, cardiovascular and endovascular devices, GI, women’s health, men’s health, diabetes, intensive care and neurology, ENT, and orthopedics.
Kevin holds an AB from Harvard University and an MBA from William and Mary, Mason School of Business.
Michele has led Trinity initiatives in strategic planning, product launch, payer, global, and commercial assessments for both established and emerging life sciences companies. With therapeutic area expertise that is broad and deep, Michele has completed over 15 years of engagements and launches in oncology, metabolics, cardiovascular, central nervous system, and a range of specialty, orphan, and traditional markets. Having started her life sciences career in industry in marketing and brand roles at AstraZeneca and Genentech, she moved to strategy and leadership roles at AmeriSource Bergen Specialty Group and Ogilvy CommonHealth Worldwide.
Michele holds a BS in biology and mathematical sciences from Montclair State University and a Masters of Public Health from Columbia University. In her spare time, she does her best to keep up with her son in high school and uses exercise as a way to process the day.
Principal, EU Office
Jackson has advised biopharmaceutical companies on their commercialization challenges for over 15 years. Clients look to Jackson to bring actionable strategic advice supported by strong analytical evidence to address their commercialization concerns. Jackson has advised clients in Europe, the US and other countries on issues ranging from Corporate and Portfolio strategy, Business Development strategy, assessment of key opportunities, Go-To-Market strategy and Launch planning. Currently a Principal in Trinity’s Munich Office, Jackson brings experience both from other consulting firms and working directly with clients as an independent advisor.
Jackson holds an MBA with Distinction from London Business School. When not in the office, Jackson likes to challenge himself with some open water swimming and did once manage to swim the English Channel.
Kevin partners with customers to implement creative, data-supported solutions. His breadth of work spans all commercial activities, such as portfolio design, new product planning, forecasting (including supporting research and analytics), launch planning & tracking, opportunity assessments, and patient services. With a deep understanding of major therapeutic areas, with specific focus on oncology, immunology, neurology, pain, and other specialty markets, he co-leads Trinity’s NYC office and helps drive the company’s forecasting innovation engine.
Kevin earned a BA from Dartmouth College and a Masters of Public Health from Tufts University. When he isn’t in the office, Kevin can be found playing basketball and tennis, or traveling with his wife, camera in hand.
Chad brings deep expertise to integrated research solutions, bridging elements of research, analytics, and strategy to inform some of our clients most complex and challenging issues. Chad’s specialty lies at the nexus of corporate strategy and asset diligence, helping customers to decide how to invest in both internal and external development opportunities, but also shape larger franchises and portfolios in an ever-evolving and competitive landscape. Chad’s work has touched billions of dollars of acquisitions over the years, both on the buy- and sell-side.
Chad earned an AB in Molecular Biology from Princeton University, where he also pole vaulted for the Track & Field team. Outside of Trinity, Chad enjoys trying a new cocktail, catching an old movie, and raising his young pup.
Amanda has been a key leader of Trinity’s strategic advisory group for a decade. Known for her expertise in new product planning, strategic business development and L&A work, Amanda also specializes in leading large, integrated projects that involve strategic advisory services, primary market research, and secondary data analytics. Over nearly a dozen years, she has developed deep expertise in central nervous system, psychiatry, and orphan disease markets.
Amanda earned a BA from Princeton University in Molecular Biology and Neuroscience. An avid runner, Amanda loves hiking on weekends with her husband, daughter, and their yellow lab.
Kevin is a thought leader with extensive experience focusing on patient-level data. Since joining Trinity, Kevin has helped cultivate a center of excellence around data and analytics. Leading Trinity’s Real-World Evidence practice, Kevin and his team focus on driving insights to inform commercial strategy and planning as well as evidence generation for health economics outcomes research (HEOR) teams.
Kevin received a B.S. in Managerial Economics and International Business from Bentley University. During his free time, Kevin stays active with his family, running trails with his family’s lab, and finding projects around the house.
Christian is a recognized and widely published expert on pricing, contracting, market access and payer evidence strategy. He leads Trinity’s pricing, market access, reimbursement and contracting (PARC) group, and has supported the development of PARC strategies for more than 50 assets in the US and ex-US. His experience includes developing US and global launch, marketing, pricing/contracting, market access, and evidence generation strategies for pharmaceutical and medical device products across multiple therapeutic areas and therapeutic settings. His work regularly puts him in touch with payers, health technology assessments (HTAs), and other critical stakeholders in the US, Europe and around the world. Christian brings direct industry experience, serving as the global pricing, market access, and health economics lead, sitting on global blood therapeutics (GBT) and GPT teams, for a major potential oncology blockbuster.
Christian has a Ph.D. in Economics from MIT and degrees from Ecole Polytechnique and Ecole Normale/EHESS in France. Christian loves that Greater Boston’s emergence as a biotechnology leader enables him to frequently bike from meeting to meeting, and spending more time with his two teenagers.
John co-leads our San Francisco office and team and drives growth in our strategic advisory service offering in Pricing, Access, Reimbursement, and Contracting (PARC). Since 1999, John has been leading strategic contracting initiatives, brand planning, forecasting, and product launch strategies to inform customers’ data-driven strategic decision making with market research, quantitative analysis, and financial modeling. His therapeutic expertise includes oncology, neurology, hemophilia, and medical devices. John is also a published author, having led several Trinity perspective pieces, including “Innovative Contracting Solutions in a Changing Healthcare Landscape” and “Why So Slow? Demystifying The Barriers To U.S. Biosimilar Adoption.”
John holds an MBA from the Kellogg School of Management and a BS in electrical engineering from the University of Michigan. A former United States Air Force officer, John runs 75-100 miles most months and enjoys the Bay Area’s outdoor lifestyle where he struggles to keep up with his three young children and their interests and activities.
Maria brings a decade of pharmaceutical market research experience to Trinity’s customers. With expertise in oncology, orphan diseases, benign hematologic conditions, and inflammation and immunology, Maria focuses on research engagements that span the patient journey, new product opportunity assessments, scenario planning, and promotional material testing.
Trained as a research scientist, Maria holds a PhD in Biology with a concentration in Immunology from Boston College. Outside of Trinity, Maria spends her time traveling and reading. She also enjoys giving back to her community as a volunteer teacher and mentor to middle school students through Citizen Schools.
Blair specializes in assisting innovative biopharma companies to create value and make strategic decisions across the product lifecycle. In particular, Blair focuses on assessing value for novel therapeutics, both as part of L&A diligence as well as for internal corporate strategy and pipeline prioritization purposes. Since joining Trinity in 2011, he has developed deep expertise in neuromuscular, neurological, autoimmune, and rare metabolic disorders and specializes in working with novel therapeutics including gene therapies, nucleotide-based therapies, and CRISPR therapeutics. Over the years, Blair has been deeply involved in bringing numerous rare disease products to successful launch.
Blair earned a BA from Princeton University in Molecular Biology and Finance. When he isn’t in the office, Blair can be found playing a variety of sports or traveling, hiking, and sightseeing with friends and family.
Caroline has a decade of life sciences consulting experience with Trinity, partnering with life science clients to generate evidence-based insights that enable strategic decision making. Her specialty lies in partnering with companies focused on commercial assessments, BD/NPP strategy, pipeline/portfolio prioritization and strategy, bringing deep expertise in rare diseases, pulmonology and immunology.
Caroline earned a healthcare systems-focused Masters of Engineering Management from Dartmouth College and a BS in Biomedical Engineering from Case Western Reserve University. Having recently relocated to the Boston area from Canada, she enjoys spending time with her husband and two spunky cats.
Lauren has been in the life sciences industry for over a decade and specializes in helping clients answer some of their ‘fuzziest’ questions. She enjoys working as a thought partner with her clients, providing structure and actionable solutions around key strategic questions. Her expertise spans many therapeutic areas, including Women’s health, neurology, and immunology. Lauren’s experience from preclinical biotechs to big pharma allows her to bring perspective tailor-made for the question at hand. She specializes in integrated projects – creating a holistic ‘so-what’ story from multiple information sources.
Lauren started her career in direct-to-consumer advertising at McCann Erickson, primarily focused on GSK’s launch of their HPV vaccine, Cervarix. Lauren holds an MBA from Tuck School of Business at Dartmouth and graduated magna cum laude from Washington and Lee University with a BS in Business Management and English. She spends her time trying to keep up with her two young children and waiting for SEC football season.
Jennifer currently leads Trinity’s Patient Centricity Center of Excellence, helping Trinity’s clients weave the Voice of the Patient into all facets of the product lifecycle. Jennifer’s group works closely with Trinity’s Strategic Advisory, PMR and RWE teams to produce deep patient insights based in real-world data, that are tactically actionable for a wide range of biopharma customers. Over the past 9 years at Trinity, Jenifer has helped clients leverage patient insights in a wide array of treatment areas, including Oncology, GI, and several orphan and neuromuscular diseases.
Jennifer has been involved in patient and consumer insights work for the past 18 years, with prior roles at Forrester Research, Quintiles Consulting, and Applied Marketing Science. Having joined Trinity in 2010, Jennifer helped develop the company’s primary research capabilities into a core part of the business, specifically in the areas of qualitative research and Patient Journey.
Jennifer earned a BA in Psychology from Boston University. When not at the office, Jennifer is most likely planning the next family vacation for her husband and 3 school-aged kids, plotting her next home improvement endeavor, or being entertained by her extremely active boxer puppy, Ruby.
Susheel heads Trinity’s Commercial Analytics group and provides operational support across demand forecasting, field operations, and ad hoc analytics to our partners in the life sciences industry. Susheel started his consulting career in pharmaceutical data management and reporting before going on to lead engagements leveraging primary research and secondary data with a focus on commercial operations and analytics. With in-depth knowledge of the pharmaceutical, biotech, and medical device industries, Susheel has worked in multiple therapeutic areas including diabetes, oncology, infectious diseases, central nervous system, and gastrointestinal disorders.
He holds a bachelor’s degree in Biomedical Engineering from the University of Mumbai and a master’s degree in Bioinformatics from Georgia Tech. Susheel enjoys family time with his wife and two children as well as swimming, music, and soccer.
Steve has broad life sciences consulting experience spanning over 20 years with emphasis on integrating commercial strategy with advanced analytics. Throughout his career, from Bristol-Meyers Squibb to consulting engagements, Steve has applied diverse research methods–including qualitative interviews, quantitative surveys and sophisticated modeling–to strategic issues in commercial development across a range of therapeutic categories and stakeholders. Since joining Trinity, Steve has been a strategic partner for many clients, leading a broad array of global engagements to inform commercialization decision points including patient journey, demand assessment, market mapping, segmentation, positioning, and promotional material development.
Steve has a Ph.D. in Political Science from the University of Wisconsin-Madison and an Economics degree from Cornell University. Outside of Trinity, Steve can be found driving his 3 boys to all regions of New Jersey for baseball and basketball games, or rowing on Lake Carnegie when everyone else is sleeping.
Ken brings to Trinity Life Sciences more than 20 years of experience within the pharmaceutical and consulting industries. His industry roles include time serving as head of pricing for GSK’s emerging market division and as global head of pricing and market access for Sandoz Biosimilars and Oncology Injectables business unit.
Ken has managed/supported engagements spanning development to commercial strategy in the EU, US and emerging markets, including: clinical trial design strategy, BD&L assessments & landscape analysis, market access strategy, pricing strategy, launch planning & execution and lifecycle management.
Ken was most recently Director in the Life Sciences Practice at Navigant/Guidehouse, where he led Global Market Access for four years. Ken holds an MA in Economics from Heriot-Watt University and an MSc in Finance from Cass Business School, London.
Manas has more than a decade of experience advising pharmaceutical clients on key marketing decisions across the product lifecycle with particular focus on pre-launch and pipeline decisions. He is an expert in the use of a wide range of techniques to develop global marketing strategies including modelling client decisions, competitive market dynamics, launch scenarios, near and long term opportunities, patient journeys, customer segments, effects of promotional activities, and positioning strategies. He has experience in several therapeutic areas, including Immunology, Diabetes, Women’s Health, and Neuroscience.
Prior to joining, Manas was a Senior Manager in ZS Associates where he led their Customer Insights group in India. He holds a Bachelor of Technology degree in Civil Engineering from the Indian Institute of Technology, Delhi.
Executive Director, Finance
Melissa leads a high-performing team, implementing scalable Customer Relationship Management (CRM) and Enterprise Resource Planning (ERP) systems, integrating acquisitions and strengthening the timing and accuracy of financial reporting. Melissa began her career in public accounting where she sharpened her technical accounting skills and gained her CPA license before transitioning into roles where she provides value within private equity-backed companies leading accounting organizations.
A self-starter who learned independence early, Melissa supported herself financially through college and graduated from UMass Boston with her bachelor’s degree in accounting. When she’s not focused on very structured accounting work, Melissa enjoys using the other side of her brain to create — cooking and gardening — and raising her two little girls, fostering their interests and helping them learn about the world.
Jeff has been focused on operational efficiency for over two decades. With expertise in recognizing business challenges and fashioning technological or process-oriented solutions that drive the business forward, Jeff oversees Trinity’s Information Technology, Compliance, Facilities, Knowledge Management and general administration. Despite his diverse industry experience, Jeff has had pharmaceutical and biotech roots since early in his career.
Jeff earned a BA in Economics at the University of Massachusetts in Amherst, Mass. In Jeff’s free time he is often traveling with his family and participating in road races, century rides and triathlons all over the world.
Michelle has a deep passion for empowering leaders and energizing culture to accelerate growth. Formerly at Wayfair and athenahealth, Michelle leverages 15 years’ experience to lead a Talent Management function that supports the integration of new hires and leaders, organizational design and succession planning, career pathing and performance management, and engagement strategies.
Michelle also has expertise in change management, leader and manager coaching, planning corporate meetings and communications, and leads Trinity’s Corporate Social Responsibility and Diversity & Inclusion platforms.
A California native, Michelle has a degree in Sociology from the University of California, Santa Barbara. Outside of work, Michelle can be found playing pub trivia or taking urban hikes to soak up the beauty and history of the Boston area.
Jessie leads all of Trinity’s core human resources functions, including recruiting. With over 15 years of experience in the human resources field, she understands the critical role people play in Trinity’s growth and the success of life sciences customers around the world. Jessie worked at SVB Leerink (formerly Leerink Swann) prior to joining Trinity.
She received her MS in Human Resource Management from Emmanuel College and earned her BS in Business Administration from the University of Vermont. Jessie enjoys spending time with her two little daughters and traveling.
Head of Marketing
Elizabeth leads Trinity’s marketing organization. She has over 25 years of experience in global marketing, public relations, brand building and advertising at life sciences and technology companies. She has a passion for building customer relationships through a combination of technology and creative communications.
Elizabeth received a BS in Public Relations from the S.I. Newhouse School of Public Communications at Syracuse University and an MBA from Boston University’s Questrom School of Business. She enjoys spending time with her family, traveling and continuously attempting an unassisted handstand in yoga class.